NEW YORK ─ Lunaphore Technologies on Tuesday announced it has raised CHF 2 million ($2.1 million) in Series C2 financing, bringing the total revenues for its Series C round to CHF 25 million.
Swiss Entrepreneurs Fund invested all CHF 2 million in the Series C2 financing round, bringing its total investment in Lunaphore to CHF 5 million. The Swiss Entrepreneurs fund is linked to the Swiss Entrepreneurs Foundation, whose focus is to invest in Swiss startups and small- and medium-sized enterprises in a growth phase, Lunaphore said.
In February, the Lausanne, Switzerland-based company had announced it raised CHF 23 million in its Series C round.
The proceeds from the overall Series C financing will be dedicated to market and product expansion, including a US market entry, the ramp up of activities in Europe, and the development of next-generation instruments, the firm said.
Lunaphore is developing next-generation tissue autostainers that use microfluidics to perform assays on cancer patient tissue samples.